Literature DB >> 12077276

Complement deficiency ameliorates collagen-induced arthritis in mice.

Max Albert Hietala1, Ing-Marie Jonsson, Andrej Tarkowski, Sandra Kleinau, Marcela Pekna.   

Abstract

Collagen-induced arthritis (CIA) is an experimental animal model of human rheumatoid arthritis being characterized by synovitis and progressive destruction of cartilage and bone. CIA is induced by injection of heterologous or homologous collagen type II in a susceptible murine strain. DBA/1J mice deficient of complement factors C3 (C3(-/-)) and factor B (FB(-/-)) were generated to elucidate the role of the complement system in CIA. When immunized with bovine collagen type II emulsified in CFA, control mice developed severe arthritis and high CII-specific IgG Ab titers. In contrast, the C3(-/-) and FB(-/-) were highly resistant to CIA and displayed decreased CII-specific IgG Ab response. A repeated bovine collagen type II exposure 3 wk after the initial immunization led to an increase in the Ab response in all mice and triggered arthritis also in the complement-deficient mice. Although the arthritic score of the C3(-/-) mice was low, the arthritis in FB(-/-) mice ranked intermediate with regard to C3(-/-) and control mice. We conclude that complement activation by both the classical and the alternative pathway plays a deleterious role in CIA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077276     DOI: 10.4049/jimmunol.169.1.454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Authors:  Masha Fridkis-Hareli; Michael Storek; Eran Or; Richard Altman; Suresh Katti; Fang Sun; Tao Peng; Jeff Hunter; Krista Johnson; Yi Wang; Ante S Lundberg; Gaurav Mehta; Nirmal K Banda; V Michael Holers
Journal:  Mol Immunol       Date:  2018-12-01       Impact factor: 4.407

2.  Pivotal advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms.

Authors:  David J Kaczorowski; Amin Afrazi; Melanie J Scott; Joon H Kwak; Roop Gill; Rebecca D Edmonds; Yujian Liu; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2010-04-22       Impact factor: 4.962

3.  Role of complement cascade in abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Robert Erdman; Larry A Donoso; Tamara R Vrabec; Charles M Schworer; John H Lillvis; Amy M Boddy; Kimberly Derr; Alicia Golden; William D Bowen; Zoran Gatalica; Nikos Tapinos; James R Elmore; David P Franklin; John L Gray; Robert P Garvin; Glenn S Gerhard; David J Carey; Gerard Tromp; Helena Kuivaniemi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

4.  Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Authors:  Nirmal K Banda; Gaurav Mehta; Viviana P Ferreira; Claudio Cortes; Matthew C Pickering; Michael K Pangburn; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

5.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

Authors:  Jinan Li; Annelii Ny; Göran Leonardsson; Kutty Selva Nandakumar; Rikard Holmdahl; Tor Ny
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6.

Authors:  B Chen; J Hu; L Liao; Z Sun; Q Han; Z Song; R C Zhao
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

Review 7.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Authors:  Guillermina Girardi; Jessica Berman; Patricia Redecha; Lynn Spruce; Joshua M Thurman; Damian Kraus; Travis J Hollmann; Paolo Casali; Michael C Caroll; Rick A Wetsel; John D Lambris; V Michael Holers; Jane E Salmon
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin.

Authors:  Marvin Lin; Na Yin; Barbara Murphy; M Edward Medof; Stephan Segerer; Peter S Heeger; Bernd Schröppel
Journal:  Diabetes       Date:  2010-06-28       Impact factor: 9.461

10.  Complement receptor 3 promotes severe ross river virus-induced disease.

Authors:  Thomas E Morrison; Jason D Simmons; Mark T Heise
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.